Bloomberg: Geron, StemCells Rise 4%

Posted: Published on September 15th, 2011

This post was added by Dr. Richardson



Geron, the first Biotech company to be FDA-approved for human clinical stem cell trials, is a large part of the stem cell discussion in the market.

Original post:
Bloomberg: Geron, StemCells Rise 4%

Related Posts
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.